NCT05066100

Brief Summary

The objectives of this study are to determine the population occurrence rate of flat, inverted, or retracted nipples (FIRN) in pregnant women in our obstetrical practice through prenatal evaluation at the NOB visit and re-evaluation at the 28th-30th week of gestation, to determine the benefit of using Supple Cups as treatment for FIRN for 6-8 weeks in the third trimester to evert the nipples prior to delivery, and to evaluate the effect of prenatal diagnosis and treatment of FIRN on establishment of latch and breastfeeding rates in the postpartum period.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 6, 2021

Completed
28 days until next milestone

First Posted

Study publicly available on registry

October 4, 2021

Completed
1.2 years until next milestone

Study Start

First participant enrolled

December 1, 2022

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
Last Updated

December 15, 2022

Status Verified

December 1, 2022

Enrollment Period

1 year

First QC Date

September 6, 2021

Last Update Submit

December 13, 2022

Conditions

Keywords

PregnancyLactationPostpartumFlat NipplesInverted NipplesRetracted Nipples

Outcome Measures

Primary Outcomes (1)

  • Percent of women with change in nipple elongation following use of Supple Cups in the prenatal period

    Visual assessment and documented description of change in elongation of nipple after using Supple Cups prior to birth

    At completion of 6 weeks of Supple Cups use during the prenatal period

Secondary Outcomes (1)

  • Percent of women with established breastfeeding with adequate infant latch

    One week postpartum

Study Arms (1)

Pregnant women with FIRN

EXPERIMENTAL

Women desiring to breastfeed and identified during their pregnancy as having flat, inverted or retracted nipples

Other: Prenatal Use of Supple Cups

Interventions

For pregnant women identified with FIRN and providing consent to participate in this study, Supple Cup usage will be initiated at 32 weeks gestation to begin to elongate the nipples in preparation for breastfeeding.

Pregnant women with FIRN

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women ≥ 18 years of age
  • Pregnant at time of enrollment
  • Plan to breastfeed their infant following birth
  • Plan delivery at Mayo Clinic Hospital
  • One or more flat, inverted or retracted nipple diagnosed by a healthcare professional

You may not qualify if:

  • History of breast surgery or nipple piercings
  • History of significant low milk supply requiring discontinuation of breastfeeding prior to six weeks postpartum
  • History of preterm labor and/or birth
  • History of high-risk medical condition that increases patient risk for preterm labor and/or birth
  • History of Raynaud's syndrome and/or hypersensitivity to palpation of breasts
  • Current multiple gestation pregnancy
  • Active rash, infection, or lesions on the nipple at time of initiation of Supple Cups

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic in Rochester, Minnesota

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Breast Feeding

Condition Hierarchy (Ancestors)

Feeding BehaviorBehavior

Study Officials

  • Miriam E Levi, CNM, MBA

    Mayo Clinic

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 6, 2021

First Posted

October 4, 2021

Study Start

December 1, 2022

Primary Completion

December 1, 2023

Study Completion

March 1, 2024

Last Updated

December 15, 2022

Record last verified: 2022-12

Locations